Publication & Citation Trends
Publications
27 total
Comparative assessment of clinical response in patients with rheumatoid arthritis between PF‐05280586, a proposed rituximab biosimilar, and rituximab PDF
Cited by 19
OpenAlex
Abatacept Plus Methotrexate Provides Incremental Clinical Benefits Versus Methotrexate Alone in Methotrexate-naive Patients with Early Rheumatoid Arthritis Who Achieve Radiographic Nonprogression PDF
Cited by 32
OpenAlex
Improvements in Participation in Usual Daily Activities in Patients with Rheumatoid Arthritis Treated with Abatacept
Cited by 7
OpenAlex
The International Normalized Ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used. OA
Cited by 59
Semantic Scholar
Novastan® (Brand of Argatroban): A Small-Molecule, Direct Thrombin Inhibitor
Cited by 165
Semantic Scholar
State-of-the-Art Review: The Preclinical and Clinical Pharmacology of Novastan (Argatroban): A Small-Molecule, Direct Thrombin Inhibitor
Cited by 31
Semantic Scholar
Research Topics
Rheumatoid Arthritis Research and Therapies
(20)
Spondyloarthritis Studies and Treatments
(11)
Autoimmune and Inflammatory Disorders Research
(8)
Biosimilars and Bioanalytical Methods
(6)
Venous Thromboembolism Diagnosis and Management
(3)
Affiliations
Bristol-Myers Squibb (Germany)
Pfizer (United States)
University of Alberta Hospital
Bristol-Myers Squibb (United States)
Bristol-Myers Squibb (Sweden)